VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 118 filers reported holding VIKING THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,586,672 | -23.0% | 595,002 | +12.8% | 2.04% | -6.3% |
| Q2 2023 | $8,553,320 | +105.5% | 527,657 | +111.1% | 2.18% | +5.7% |
| Q1 2023 | $4,162,500 | +44.0% | 250,000 | -75.0% | 2.06% | +89.7% |
| Q2 2022 | $2,890,000 | -3.6% | 999,829 | 0.0% | 1.08% | +9.4% |
| Q1 2022 | $2,999,000 | -1.3% | 999,829 | +51.3% | 0.99% | +8.3% |
| Q4 2021 | $3,040,000 | -26.7% | 660,813 | 0.0% | 0.92% | -30.8% |
| Q3 2021 | $4,150,000 | +11.8% | 660,813 | +6.6% | 1.32% | +43.3% |
| Q2 2021 | $3,712,000 | +3.0% | 619,780 | +8.8% | 0.92% | +26.1% |
| Q1 2021 | $3,604,000 | +5.0% | 569,780 | -6.6% | 0.73% | +4.1% |
| Q4 2020 | $3,433,000 | -16.9% | 609,780 | -14.1% | 0.70% | -14.1% |
| Q3 2020 | $4,131,000 | -19.3% | 709,780 | 0.0% | 0.82% | -45.2% |
| Q2 2020 | $5,118,000 | +45.4% | 709,780 | -5.6% | 1.49% | +26.6% |
| Q1 2020 | $3,520,000 | -40.0% | 752,241 | +2.8% | 1.18% | -15.5% |
| Q4 2019 | $5,866,000 | +13.0% | 731,453 | -3.1% | 1.40% | -16.5% |
| Q3 2019 | $5,193,000 | -17.1% | 754,759 | 0.0% | 1.67% | +10.8% |
| Q2 2019 | $6,264,000 | -26.0% | 754,759 | -11.4% | 1.51% | -34.0% |
| Q1 2019 | $8,470,000 | +73.8% | 852,160 | +33.8% | 2.29% | +28.8% |
| Q4 2018 | $4,873,000 | +31.2% | 637,046 | +198.7% | 1.78% | +39.2% |
| Q3 2018 | $3,715,000 | +39.1% | 213,252 | -24.2% | 1.28% | -13.6% |
| Q2 2018 | $2,670,000 | -52.2% | 281,304 | -78.0% | 1.48% | -56.0% |
| Q1 2018 | $5,580,000 | +9.9% | 1,276,845 | +2.1% | 3.35% | +17.1% |
| Q4 2017 | $5,076,000 | +326.2% | 1,250,250 | +47.1% | 2.86% | +248.7% |
| Q3 2016 | $1,191,000 | +70.4% | 849,905 | +53.3% | 0.82% | +130.0% |
| Q2 2016 | $699,000 | – | 554,382 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |